Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 33
| Issue Date | Title | Author(s) |
| Mar-2024 | Adapted problem adaptation therapy for depression in mild to moderate Alzheimer's disease dementia: A randomized controlled trial | Wilkinson, Philip; OHFT Research & Development |
| Apr-2023 | Do communication interventions affect the quality-of-life of people with dementia and their families? A systematic review | Moll, Deborah; Littlejohns, Jemima; Collett, Zoe; Henshall, Catherine; Nurse |
| Apr-2022 | The impact of social isolation due to the COVID-19 pandemic on patients with dementia and caregivers | Raymont, Vanessa; Colston, Amanda |
| Feb-2022 | Personalised treatment for cognitive impairment in dementia: development and validation of an artificial intelligence model | Cipriani, Andrea |
| Feb-2022 | Identification of Substrate-specific Allosteric Fingerprints in Matrix Metalloprotease-1 on Amyloid-beta Peptide Aggregates and Drug Screening With Single Molecule Insights | External author(s) only |
| Feb-2022 | Early- and subsequent- response of cognitive functioning in Alzheimer's disease: Individual-participant data from five pivotal randomized clinical trials of donepezil | Cipriani, Andrea |
| Dec-2021 | Patient attitudes towards remote memory clinic assessment | Blane, Jasmine; O'Donoghue, M Clare; Craig, Emma; Raymont, Vanessa; Mackay, Clare; Martos, Lola |
| Nov-2021 | Neurons derived from individual early Alzheimer’s disease patients reflect clinical vulnerability | External author(s) only |
| Sep-2021 | Effect of trazodone on cognitive decline in people with dementia: Cohort study using UK routinely collected data | Smith, Tanya |
| Mar-2021 | Ethics of Early Intervention in Alzheimer’s Disease | External author(s) only |
| Mar-2021 | Development and Validation of a Novel Dementia Risk Score in the UK Biobank Cohort | External author(s) only |
| Feb-2021 | Quantifying the heterogeneity of cognitive functioning in Alzheimer’s disease to extend the placebo-treatment dichotomy: Latent class analysis of individual-participant data from five pivotal randomized clinical trials of donepezil | Cipriani, Andrea |
| Dec-2020 | Can dietary supplements maintain cognition in mid- to late-life? | Smith, Alexander L W; Medical Trainee |
| Feb-2019 | Valproate in dementia: time to move on? Commentary on…Cochrane Corner | Dhindsa, Amreek; Medical Trainee |
| Jan-2021 | Quantification of allosteric communications in matrix metalloprotease-1 on alpha-synuclein aggregates and substratedependent virtual screening | External author(s) only |
| Jan-2021 | Incidence of neurodegenerative and cerebrovascular diseases associated with antihypertensive drug classes | Harrison, Paul J; Colbourne, Lucy |
| Sep-2020 | The impact of assistive technology on burden and psychological well-being in informal caregivers of people with dementia (ATTILA Study) | Howard, Robert |
| Apr-2020 | Vascular Dementia | Series, Hugh |
| Oct-2020 | Linking the Mini-Mental State Examination, the Alzheimer’s Disease Assessment Scale–Cognitive Subscale and the Severe Impairment Battery: evidence from individual participant data from five randomised clinical trials of donepezil | Cipriani, Andrea |
| Jul-2020 | Health Outcome Prioritization in Alzheimer's Disease: Understanding the Ethical Landscape. | External author(s) only |
Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 33
